{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:23:19Z","timestamp":1792513399986,"version":"4.5.0"},"update-to":[{"DOI":"10.1371\/journal.pntd.0007072","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T00:00:00Z","timestamp":1550102400000}}],"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T00:00:00Z","timestamp":1548806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0007072","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T13:48:11Z","timestamp":1548856091000},"page":"e0007072","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":109,"title":["Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo"],"prefix":"10.1371","volume":"13","author":[{"given":"Caroline S.","family":"de Freitas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiza M.","family":"Higa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Q.","family":"Sacramento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 C.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia A.","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Delvecchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio L.","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giselle","family":"Barbosa-Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrison","family":"James Westgarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmine Rangel","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayara","family":"Mattos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas Villas B\u00f4as","family":"Hoelz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rennan Papaleo Paes","family":"Leme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f4nica M.","family":"Bastos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisele Olinto","family":"L. Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0529-1404","authenticated-orcid":true,"given":"Carla Elizabeth","family":"M. Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celso Martins","family":"Queiroz-Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiano X.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian V.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro M.","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando A.","family":"Bozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8349-9529","authenticated-orcid":true,"given":"Patr\u00edcia T.","family":"Bozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nubia","family":"Boechat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amilcar","family":"Tanuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2212-3899","authenticated-orcid":true,"given":"Thiago Moreno L.","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,1,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.antiviral.2014.12.010","article-title":"Yellow fever virus: genetic and phenotypic diversity and implications for detection, prevention and therapy","volume":"115","author":"DW Beasley","year":"2015","journal-title":"Antiviral Res"},{"issue":"7598","key":"ref2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/532155a","article-title":"Fears rise over yellow fever's next move","volume":"532","author":"D Butler","year":"2016","journal-title":"Nature"},{"key":"ref3","unstructured":"@NewsfromScience. When will yellow fever strike Brazil again? Monkeys and mosquitoes hold clues | Science | AAAS. 2017. Available from: https:\/\/ https:\/\/www.sciencemag.org\/news\/2017\/08\/when-will-yellow-fever-strike-brazil-again-monkeys-and-mosquitoes-hold-clues<\/ext-link>"},{"key":"ref4","unstructured":"Villegoureix I. PAHO\/WHO | 20 March 2018: Yellow Fever\u2014Epidemiological Update 2018 [updated 2018-03-20 19:57:54. Available from: https:\/\/www.paho.org\/hq\/index.php?option=com_content&view=article&id=14207:20-march-2018-yellow-fever-epidemiological-update&Itemid=42346\u2329=en<\/ext-link>."},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.1038\/s41598-017-07873-7","article-title":"Phylodynamics of Yellow Fever Virus in the Americas: new insights into the origin of the 2017 Brazilian outbreak","volume":"7","author":"D Mir","year":"2017","journal-title":"Scientific Reports"},{"key":"ref6","unstructured":"Amarela CF. MONITORAMENTO DOS CASOS E \u00d3BITOS DE FEBRE AMARELA NO BRASIL, INFORME\u2013N\u00ba 43\/2017 2017 [Available from: http:\/\/portalarquivos2.saude.gov.br\/images\/pdf\/2017\/junho\/02\/COES-FEBRE-AMARELA\u2014INFORME-43\u2014Atualiza\u2014-o-em-31maio2017.pdf<\/ext-link>."},{"key":"ref7","first-page":"1","article-title":"(CDC) CfDCaP. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"JE Staples","year":"2010","journal-title":"MMWR Recomm Rep"},{"issue":"48","key":"ref8","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1016\/j.vaccine.2008.09.009","article-title":"Adverse event reports following yellow fever vaccination","volume":"26","author":"NP Lindsey","year":"2008","journal-title":"Vaccine"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"40920","DOI":"10.1038\/srep40920","article-title":"The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication","volume":"7","author":"CQ Sacramento","year":"2017","journal-title":"Scientific Reports"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"9409","DOI":"10.1038\/s41598-017-09797-8","article-title":"Sofosbuvir protects Zika virus-infected mice from mortality, preventing short- and long-term sequelae","volume":"7","author":"AC Ferreira","year":"2017","journal-title":"Scientific Reports"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.antiviral.2016.11.023","article-title":"The FDA-approved drug sofosbuvir inhibits Zika virus infection","volume":"137","author":"KM Bullard-Feibelman","year":"2017","journal-title":"Antiviral Res"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"6345","DOI":"10.1038\/s41598-017-06612-2","article-title":"Evaluation of Sofosbuvir (\u03b2-D-2\u2032-deoxy-2\u2032-\u03b1-fluoro-2\u2032-\u03b2-C-methyluridine) as an inhibitor of Dengue virus replication","volume":"7","author":"H-T Xu","year":"2017","journal-title":"Scientific Reports"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4103\/0976-500X.142464","article-title":"Sofosbuvir: A novel treatment option for chronic hepatitis C infection","volume":"5","author":"HK Bhatia","year":"2014","journal-title":"J Pharmacol Pharmacother"},{"key":"ref14","unstructured":"Gilead. Product Monograph Pr SOVALDI (sofosbuvir) Tablets 400 mg sofosbuvir Antiviral Agent 2015 [Available from: http:\/\/www.gilead.ca\/pdf\/ca\/sovaldi_pm_english.pdf<\/ext-link>."},{"key":"ref15","unstructured":"European Medicines Agency, EMA. Sovaldi 2013 [Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR__Public_assessment_report\/human\/002798\/WC500160600.pdf<\/ext-link>."},{"key":"ref16","unstructured":"Gilead Sciences Canada I. Product Monograph SOVALDI (sofosbuvir) Tablets 400 mg sofosbuvir Antiviral Agent 2015 [Available from: http:\/\/www.gilead.ca\/application\/files\/3915\/2589\/0723\/Sovaldi_English_PM_e162880-GS-007.pdf<\/ext-link>."},{"key":"ref17","unstructured":"FDA FaDA. Copegus (ribavirin) tablets 2015 [Available from: http:\/\/www.fda.gov\/Safety\/MedWatch\/SafetyInformation\/ucm218877.htm<\/ext-link>."},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.antiviral.2007.08.011","article-title":"Inhibition of HSV-1 replication and HSV DNA polymerase by the chloroxoquinolinic ribonucleoside 6-chloro-1,4-dihydro-4-oxo-1-(beta-D-ribofuranosyl) quinoline-3-carboxylic acid and its aglycone","volume":"77","author":"TML Souza","year":"2008","journal-title":"Antiviral Research"},{"issue":"20","key":"ref19","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1182\/blood-2013-05-504449","article-title":"Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation","volume":"122","author":"ED Hottz","year":"2013","journal-title":"Blood"},{"issue":"27","key":"ref20","article-title":"A simple method of estimating fifty percent endpoints","author":"LJ Reed","year":"1938"},{"issue":"6405","key":"ref21","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1126\/science.aat7115","article-title":"Genomic and epidemiological monitoring of yellow fever virus transmission potential","volume":"361","author":"NR Faria","year":"2018","journal-title":"Science"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1128\/JVI.01531-10","article-title":"The IFITM proteins inhibit HIV-1 infection","volume":"85","author":"J Lu","year":"2011","journal-title":"J Virol"},{"issue":"13","key":"ref23","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1093\/nar\/gkg563","article-title":"ExPASy: The proteomics server for in-depth protein knowledge and analysis","volume":"31","author":"E Gasteiger","year":"2003","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12033-008-9127-7","article-title":"Data deposition and annotation at the worldwide protein data bank","volume":"42","author":"S Dutta","year":"2009","journal-title":"Mol Biotechnol"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","article-title":"Comparative protein modelling by satisfaction of spatial restraints","volume":"234","author":"A Sali","year":"1993","journal-title":"J Mol Biol"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"TI. PROCHECK: a program to check the stereochemical quality of protein structures","volume":"26","author":"R. A. Laskowski MWM","year":"1993","journal-title":"Journal of Applied Crystallography"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0076-6879(97)77022-8","article-title":"VERIFY3D: assessment of protein models with three-dimensional profiles","volume":"277","author":"D Eisenberg","year":"1997","journal-title":"Methods Enzymol"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.joca.2012.02.010","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"20","author":"C Kilkenny","year":"2012","journal-title":"Osteoarth Cartil"},{"key":"ref29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001663","article-title":"A Model of DENV-3 Infection That Recapitulates Severe Disease and Highlights the Importance of IFN-\u03b3 in Host Resistance to Infection","volume":"6","author":"VV Costa","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"48","key":"ref30","doi-asserted-by":"crossref","first-page":"14834","DOI":"10.1073\/pnas.1514978112","article-title":"Molecular basis for specific viral RNA recognition and 2'-O-ribose methylation by the dengue virus nonstructural protein 5 (NS5)","volume":"112","author":"Y Zhao","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6223","key":"ref31","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1126\/science.1259210","article-title":"Viral replication. Structural basis for RNA replication by the hepatitis C virus polymerase","volume":"347","author":"TC Appleby","year":"2015","journal-title":"Science"},{"issue":"7","key":"ref32","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1128\/JVI.76.7.3482-3492.2002","article-title":"Structural analysis of the hepatitis C virus RNA polymerase in complex with ribonucleotides","volume":"76","author":"S Bressanelli","year":"2002","journal-title":"J Virol"},{"issue":"7","key":"ref33","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1128\/AAC.47.7.2293-2298.2003","article-title":"Synergistic in vitro interactions between alpha interferon and ribavirin against bovine viral diarrhea virus and yellow fever virus as surrogate models of hepatitis C virus replication","volume":"47","author":"VE Buckwold","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.antiviral.2006.08.008","article-title":"Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster model","volume":"73","author":"JG Julander","year":"2007","journal-title":"Antiviral Res"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1124\/mol.105.020057","article-title":"The anti-yellow fever virus activity of ribavirin is independent of error-prone replication","volume":"69","author":"P Leyssen","year":"2006","journal-title":"Mol Pharmacol"},{"issue":"7658","key":"ref36","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nature22402","article-title":"Zika virus evolution and spread in the Americas","volume":"546","author":"HC Metsky","year":"2017","journal-title":"Nature"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1590\/0074-02760150192","article-title":"First report of autochthonous transmission of Zika virus in Brazil","volume":"110","author":"C Zanluca","year":"2015","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref38","article-title":"Secretaria Municipal de Sa\u00fade. Boletim da Febre do Chikungunya","author":"F de Santana","year":"2014","journal-title":"Situa\u00e7\u00e3o epidemiol\u00f3gica dos casos de chikungunya"},{"issue":"Suppl 1","key":"ref39","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1590\/S0102-311X2009001300002","article-title":"Dengue: twenty-five years since reemergence in Brazil","volume":"25","author":"MG Teixeira","year":"2009","journal-title":"Cad Saude Publica"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"40920","DOI":"10.1038\/srep40920","article-title":"The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication","volume":"7","author":"CQ Sacramento","year":"2017","journal-title":"Sci Rep"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jcv.2014.08.030","article-title":"Yellow fever","volume":"64","author":"TP Monath","year":"2015","journal-title":"J Clin Virol"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.trstmh.2006.04.001","article-title":"Clinical and epidemiological characteristics of yellow fever in Brazil: analysis of reported cases 1998\u20132002","volume":"101","author":"SH Tuboi","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"ref43","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.trstmh.2006.02.019","article-title":"Hepatocyte lesions and cellular immune response in yellow fever infection","volume":"101","author":"JA Quaresma","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-pathol-020712-164041","article-title":"Pathogenesis of the viral hemorrhagic fevers","volume":"8","author":"S Paessler","year":"2013","journal-title":"Annu Rev Pathol"},{"key":"ref45","article-title":"Liver transplantation for fulminant hepatitis due to yellow fever","author":"ATW Song","year":"2018","journal-title":"Hepatology"},{"key":"ref46","unstructured":"Paulo F-FdMdUdS. The first liver transplant due to Yellow Fever patient will be discharged from the hospital his week 2018 [Available from: http:\/\/www.fm.usp.br\/en\/news\/the-first-liver-transplant-due-to-yellow-fever-patient-will-be-discharged-from-the-hospital-his-week<\/ext-link>."},{"issue":"6","key":"ref47","first-page":"850","article-title":"Maxwell Finland Laboratory for Infectious Diseases BMC, Boston, Massachusetts. Yellow Fever: Epidemiology and Prevention","volume":"44","author":"ED Barnett","year":"2018","journal-title":"Clinical Infectious Diseases"},{"issue":"10","key":"ref48","doi-asserted-by":"crossref","first-page":"e1000614","DOI":"10.1371\/journal.ppat.1000614","article-title":"A mouse model for studying viscerotropic disease caused by yellow fever virus infection","volume":"5","author":"KC Meier","year":"2009","journal-title":"PLoS Pathog"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s40264-016-0420-2","article-title":"Pharmacokinetics, Efficacy, and Safety of Hepatitis C Virus Drugs in Patients with Liver and\/or Renal Impairment","volume":"39","author":"EJ Smolders","year":"2016","journal-title":"Drug Saf"},{"issue":"4","key":"ref50","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1086\/596309","article-title":"Randomized, controlled trial of oral ribavirin for Japanese encephalitis in children in Uttar Pradesh, India","volume":"48","author":"R Kumar","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref51","article-title":"Beyond members of the Flaviviridae family, sofosbuvir also inhibits chikungunya virus replication","author":"AC Ferreira","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"19","key":"ref52","doi-asserted-by":"crossref","first-page":"7202","DOI":"10.1021\/jm100863x","article-title":"Discovery of a \u03b2-d-2'-deoxy-2'-\u03b1-fluoro-2'-\u03b2-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus","volume":"53","author":"MJ Sofia","year":"2010","journal-title":"J Med Chem"},{"issue":"5","key":"ref53","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02587-17","article-title":"Sofosbuvir and Ribavirin Liver Pharmacokinetics in Patients Infected with Hepatitis C Virus","volume":"62","author":"D Babusis","year":"2018","journal-title":"Antimicrob Agents Chemother"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0007072","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T00:00:00Z","timestamp":1550102400000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0007072","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T05:20:14Z","timestamp":1589001614000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0007072"}},"subtitle":[],"editor":[{"given":"Samuel V.","family":"Scarpino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,1,30]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0007072","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/266361","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,30]]}}}